Internal Medicine, Medical Oncology · Castro Valley, CA
NPI
1558780825
Since 2014
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
20055 Lake Chabot Rd Ste 130
Castro Valley, CA, 94546
Phone (888) 924-1024
Groups this clinician bills Medicare through
Medicare paid, 2024
$654K
57,243 services
Medicare patients, 2024
440
Average age 75
Drug cost, 2024
$896K
583 prescriptions
Company payments, 2025
$19.1
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arpeet T Shah was code J1439 (injection, ferric carboxymaltose, 1 mg), 31,500 times for 21 patients. In total Arpeet T Shah billed 57,243 services in 87 codes, and Medicare paid $654K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 31,500 | 21 | $0.87 | $27K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2,800 | 13 | $2.26 | $6,339 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 560 | 189 | $14.37 | $8,047 |
| 99214 Office E&M - Established | Office | 550 | 222 | $110.26 | $61K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 368 | 23 | $0.09 | $33.13 |
| 99215 Office E&M - Established | Office | 309 | 69 | $163.78 | $51K |
| 85025 Blood Count | Office | 255 | 110 | $7.61 | $1,941 |
| 36415 Venipuncture Blood Collection | Office | 163 | 120 | $8.65 | $1,410 |
| 99232 Hospital E&M - Subsequent | Facility | 117 | 68 | $69.02 | $8,076 |
| 99213 Office E&M - Established | Office | 112 | 75 | $82.43 | $9,232 |
| 96375 Injection Administration | Office | 99 | 28 | $15.88 | $1,572 |
| 99233 Hospital E&M - Subsequent | Facility | 94 | 52 | $104.85 | $9,856 |
| 96372 Injection Administration | Office | 88 | 35 | $13.84 | $1,218 |
| 96365 Intravenous Infusion, Hydration | Office | 65 | 35 | $64.95 | $4,221 |
| 99223 Hospital E&M - Initial | Facility | 65 | 56 | $148.80 | $9,672 |
By year: 2022 $624K for 95,822 services; 2023 $682K for 75,382 services; 2024 $654K for 57,243 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 255 | 110 | $7.61 | $1,941 |
| 36415 Venipuncture Blood Collection | 163 | 120 | $8.65 | $1,410 |
Medicare prescription drug claims, 2024
In 2024, the drug Arpeet T Shah prescribed most often to Medicare patients was Eliquis (Apixaban), with 88 prescriptions and refills. In total Arpeet T Shah wrote 583 Medicare prescriptions that cost $896K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 88 | 102 | 21 | $61K |
| Prednisone Generic | 45 | 47 | 13 | $233 |
| Anastrozole Generic | 37 | 84 | Under 11 | $554 |
| Ondansetron Hcl Generic | 20 | 20 | 11 | $315 |
| Prochlorperazine Maleate Generic | 19 | 19 | Under 11 | $186 |
| Hydroxyurea Generic | 18 | 48 | Under 11 | $335 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 16 | 16 | Under 11 | $404 |
| Imbruvica Ibrutinib | 15 | 15 | Under 11 | $231K |
| Iressa Gefitinib | 13 | 13 | Under 11 | $48K |
| Imatinib Mesylate Generic | 13 | 13 | Under 11 | $1,874 |
| Xarelto Rivaroxaban | 13 | 17 | Under 11 | $9,378 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 11 | Under 11 | $48.07 |
| Brukinsa Zanubrutinib | 11 | 11 | Under 11 | $121K |
Brand drugs: 181 claims; generic drugs: 402 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arpeet T Shah $19.1 ($19.1 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $19.1.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $19.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.